T. Rowe Price Associates’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.07M Buy
2025
Q1
$1.69M Buy
2024
Q4
$2.44M Sell
2024
Q3
$3.97M Buy
2024
Q2
$3.16M Sell
2024
Q1
$5.04M Buy
2023
Q4
$1.03M Buy
2023
Q3
$459K Sell
2023
Q2
$739K Buy